You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Brazil to start producing coronavirus vaccine in first half of 2021

"That has always been our goal. By incorporating production technology to the maximum, we hope to have 100 percent national production in the first half (of this year). We are very confident," Krieger

Topics
Brazil | Coronavirus | Coronavirus Vaccine

IANS  |  Rio de Janeiro 

Photo: Bloomberg
Brazil is set to receive more than 2 million doses of the AstraZeneca vaccine on Tuesday, according to Krieger.

will begin to produce a Covid-19 vaccine in the first half of 2021, a state-run biological sciences institution has said.

With a technology transfer agreement with British pharmaceutical company AstraZeneca, Oswaldo Cruz Foundation based in Rio de Janeiro will be able to start making the vaccine in in April, said Marco Aurelio Krieger, the vice president of production and innovation in health with the foundation, in an interview with the UOL internet portal on Monday, Xinhua reported.

"That has always been our goal. By incorporating production technology to the maximum, we hope to have 100 percent national production in the first half (of this year). We are very confident," Krieger said.

He stressed the importance to of producing its own Covid-19 vaccine to reduce dependence on other manufacturers amid a high global demand for vaccines.

"If today we wanted to buy more vaccines, we would not be able to ... It is time to think about the strategic production of some products, because we have seen global competition throughout the pandemic," he said.

Brazil is set to receive more than 2 million doses of the AstraZeneca vaccine on Tuesday, according to Krieger.

The AstraZeneca vaccine and the CoronaVac vaccine developed by Chinese pharma company Sinovac are the two vaccines being applied in the country.

"I am convinced that in April, May or June, we will be very close to having distributed 100 million doses," he added.

--IANS

int/pgh

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 23 2021. 08:50 IST
RECOMMENDED FOR YOU